Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label study of 5-MTHF in congenital homocystinuria
2006-000614-21Phase 2Completed
- Sponsor
- Zambon
- Start
- Jun 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of levomefolate calcium in homocystinuria (HCU), sponsored by Zambon. Primary endpoint: Change in plasma total homocysteine at 3 months. Started Jun 2006; status: completed.
02
Drugs
levomefolate calcium
03
Conditions
homocystinuria (HCU)
Beyond the preview
Go deeper on 2006-000614-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000614-21.